Cipla’s arm to expand consumer health business: Report

30 Nov 2017 Evaluate

Cipla’s consumer healthcare arm - Cipla Health has reportedly plans to revitalize its over-the-counter (OTC) consumer business through more in-house launches and brand acquisitions in the coming quarters.

The company is looking at new product launches in segments such as gastrointestinal, pain and analgesic, cough and cold and nutritional supplements. It is also actively looking at any kind of inorganic growth through mergers and acquisitions.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.


Cipla Share Price

1407.85 2.45 (0.17%)
26-Apr-2024 09:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1521.50
Dr. Reddys Lab 6253.15
Cipla 1407.85
Zydus Lifesciences 954.75
Lupin 1608.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.